hirly

Iovance Biotherapeutics

Vice President, Research

Tampa, Florida, United States · Philadelphia, Pennsylvania, United States

hirly Pro

Get in front of the people hiring at Iovance Biotherapeutics

  • Reach the hiring manager at Iovance Biotherapeutics on LinkedIn, from your own account
  • hirly applies to this job for you, with unlimited applications
  • A resume and cover letter written for this job, unlimited
  • The hiring manager and recruiter at Iovance Biotherapeutics, with contact details
Get Pro for this job →

$49 a month · ₹1,999 for 30 days in India · cancel any time

See how you match this job — and similar ones. Free.

Upload your resume and hirly scores it against this role at Iovance Biotherapeutics first, then against similar open jobs, and shows where you fit and why.

PDF or DOCX, up to 12MB. No sign-up to see your matches.

Get past the screening software and onto a recruiter's desk

hirly rewrites your resume for this job — matching the keywords and skills in the posting, moving your most relevant experience to the top, and writing a cover letter to fit. About 30 seconds.

  • Keywords matched to this posting
  • Fit score before you apply
  • Cover letter included

Matched against 2.2M live jobs from 220,000+ employers in 200+ countries.

Tailor my resume for this job →

Apply from your AI assistant

Connect hirly to Claude or ChatGPT and ask it to apply to this job. hirly tailors your resume, fills the employer’s form and asks before sending.

Some employer sites stop an application at a CAPTCHA or sign-in and hand it back with a link. Applying needs a paid plan. Works with any assistant that supports MCP.

hirly's read of this role

Seniority
Executive
Country
US
Work mode
Remote-friendly
First seen by hirly
18 Nov 2026

Derived automatically from the posting. Upload your resume above to see how the role scores against it.

the posting

About Iovance Biotherapeutics, Inc.

Iovance Biotherapeutics , Inc. is the global leader in innovating, developing, and delivering tumor infiltrating lymphocyte (TIL) cell therapies for patients with solid tumors. Amtagvi® (lifileucel) is the first FDA-approved, one-time treatment for previously treated advanced melanoma, now approved in three global markets and available at more than 95 authorized treatment centers. The Iovance TIL platform spans registrational trials and next-generation programs in additional solid tumors, including gene-edited and IL-12 tethered TIL therapies, next-generation IL-2, and precision immuno-oncology approaches. As the first and only company to take TIL therapy from concept to a broadly accessible commercial treatment, Iovance operates as an end-to-end cell therapy company, anchored by fully owned, centralized U.S.-based manufacturing that is scaled to serve thousands of cancer patients worldwide each year. For more information, please visit www.iovance.com .

Amtagvi® and its accompanying design marks, Proleukin ® , Iovance ® , and IovanceCares™ are trademarks and registered trademarks of Iovance Biotherapeutics, Inc. or its subsidiaries. All other trademarks and registered trademarks are the property of their respective owners.

Information on Iovance’s broad, industry-leading patent portfolio is available on the Intellectual Property page on www.iovance.com .

Overview

The Vice President, Research will provide strategic and operational leadership across translational sciences, platform research, bioinformatics, and preclinical research activities supporting Iovance’s industry-leading tumor infiltrating lymphocyte (TIL) therapy platform and next-generation cellular immunotherapy pipeline.

As the leader in commercializing the first FDA-approved TIL therapy, Amtagvi®, Iovance is pioneering innovative approaches to harness the immune system to treat solid tumors. Reporting to the Executive Vice President, Translational Medicine & Research, the VP, Research will play a critical role in advancing discovery and translational research programs, driving IND-enabling activities, and expanding the scientific foundation of Iovance’s cellular therapy platforms.

The ideal candidate is an accomplished biotechnology leader with deep expertise in cell therapy, tumor immunology, translational medicine, and preclinical drug development. This individual will oversee multidisciplinary scientific teams spanning translational sciences, bioinformatics, platform research, and preclinical development, while partnering cross-functionally to accelerate innovative therapies into the clinic.

Essential Functions and Responsibilities

Scientific & Strategic Leadership

Lead and oversee translational sciences, platform research, bioinformatics, and preclinical research functions supporting Iovance’s TIL therapy and immuno-oncology pipeline.

Partner closely with the EVP, Translational Medicine & Research to define and execute research strategy aligned with corporate and pipeline objectives.

Advance next-generation cellular therapy approaches through innovation in tumor immunology, immune cell engineering, and translational biology.

Drive scientific rigor, innovation, and operational excellence across research and translational programs.

Translational Sciences & IND-Enabling Research

Lead translational medicine strategies supporting biomarker discovery, patient selection, mechanism-of-action studies, and translational endpoints.

Oversee IND-enabling research activities, including preclinical pharmacology, proof-of-concept studies, and translational data packages supporting regulatory submissions.

Ensure effective integration of translational findings into clinical development strategies and decision-making.

Collaborate with Regulatory, Clinical Development, and CMC teams to support successful advancement of programs into clinical trials.

Platform & Preclinical Research Leadership

Provide scientific leadership for platform research initiatives focused on advancing and differentiating Iovance’s cellular therapy technologies.

Oversee preclinical research activities supporting pipeline expansion and next-generation platform innovation.

Guide evaluation and implementation of emerging technologies relevant to cell therapy, protein sciences, bioinformatics, and viral/vector-related approaches.

Bioinformatics & Computational Biology

Lead bioinformatics and computational biology capabilities supporting genomic, transcriptomic, proteomic, and multi-omic analyses.

Ensure computational and translational insights are integrated into research strategy, target identification, biomarker development, and clinical translation.

Cross-Functional Collaboration

Collaborate closely with Clinical Development, Technical Operations, Manufacturing, Regulatory Affairs, and CMC teams to advance programs from discovery through early clinical development.

Contribute scientific leadership to portfolio prioritization, governance discussions, and external partnership evaluations.

Support diligence activities and scientific assessments for external collaborations and platform opportunities.

Team Leadership & Organizational Development

Build, mentor, and lead high-performing multidisciplinary scientific teams.

Foster a culture of innovation, accountability, collaboration, and scientific excellence.

Recruit and retain top scientific talent within a fast-paced and evolving biotechnology environment.

External Scientific Engagement

Represent Iovance within the scientific and medical community through publications, conferences, scientific advisory interactions, and external collaborations.

Maintain awareness of scientific and competitive developments across cell therapy, immuno-oncology, and translational medicine landscapes.

Required Education, Skills, and Knowledge

Education

PhD, MD, or MD/PhD in Immunology, Oncology, Molecular Biology, Cell Biology, Bioengineering, or related scientific discipline required.

Experience

15+ years of biotechnology or pharmaceutical industry experience with progressive scientific leadership responsibilities.

Significant experience in cell therapy, immuno-oncology, or advanced therapeutic modalities.

Demonstrated leadership of translational sciences, preclinical research, and IND-enabling programs supporting oncology therapeutics.

Deep scientific expertise in tumor immunology, translational medicine, and cellular therapy research.

Experience overseeing or closely partnering with bioinformatics and computational biology functions.

Knowledge of viral vector technologies, engineered cell therapies, and protein sciences strongly preferred.

Prior experience with TIL, TCR, CAR-T, NK cell, or other adoptive cellular therapy platforms highly desirable.

Proven track record advancing discovery and preclinical programs into clinical development.

Experience leading multidisciplinary scientific organizations within a dynamic biotechnology environment.

Core Competencies

Scientific leadership in cellular immunotherapy

Translational and preclinical development expertise

Strategic and innovative thinking

Deep understanding of tumor immunology and cell therapy

Cross-functional leadership and collaboration

Talent development and organizational leadership

Executive communication and stakeholder engagement

The physical demands described here represent those that an employee must meet to perform the essential functions of this job successfully. Reasonable accommodation may be made upon request to enable individuals to perform essential functions. Please contact Human Resources to request accommodation.

Physical Demands and Activities Required

Must be able to move to and from the office to the lab located on separate floors and move about the office and lab as needed.

Must be able to remain in a stationary position standin

Original posting on Iovance Biotherapeutics's site ↗

Listed on hirly, a job board. hirly is not the employer: Iovance Biotherapeutics is hiring for this role.

Browse similar roles

Want this one?

Upload your resume and hirly rewrites it for this job and writes the cover letter — in about thirty seconds, before you sign up.

Tailor my resume for this job